BIM
ALXA

BlackRock Investment Management’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

BlackRock Investment Management’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,066
Closed -$6K – 4254
2015
Q1 		$6K Hold
3,066
– – ﹤0.01% 3840
2014
Q4 		$5K Hold
3,066
– – ﹤0.01% 3948
2014
Q3 		$7K Buy
3,066
+231
+8% +$882 ﹤0.01% 3827
2014
Q2 		$13K Buy
+2,835
New +$12.2K ﹤0.01% 3556

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $416M AUM 13.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BlackRock Investment Management's ALXA Position: Q2 2015 in Review

BlackRock Investment Management sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2015, closing a stake of 3,066 shares — an estimated $6K sold.

BlackRock Investment Management first reported a position in ALXA in Q2 2014 and held it in 4 quarters. The position peaked at $13K in Q2 2014. 22 funds tracked by Wall St. Rank hold ALXA as of Q2 2015.

  • BlackRock Investment Management reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • BlackRock Investment Management sold 3,066 Alexza Pharmaceuticals Inc shares in Q2 2015, an estimated $6K.
  • BlackRock Investment Management first reported a position in Alexza Pharmaceuticals Inc in Q2 2014 and held it in 4 quarters.
  • BlackRock Investment Management's Alexza Pharmaceuticals Inc position peaked at $13K in Q2 2014.
  • 22 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2015.

Based on BlackRock Investment Management's 13F filing for Q2 2015, filed 7 Aug 2015.